67461
document
Oxytocin improves behavioural and neural deficits in inferring others ' social emotions in autism . Recent studies have suggested oxytocin 's therapeutic effects on deficits in social communication and interaction in autism spectrum disorder through improvement of emotion recognition with direct emotional cues , such as facial expression and voice prosody . Although difficulty in understanding of others ' social emotions and beliefs under conditions without direct emotional cues also plays an important role in autism spectrum disorder , no study has examined the potential effect of oxytocin on this difficulty . Here , we sequentially conducted both a case-control study and a clinical trial to investigate the potential effects of oxytocin on this difficulty at behavioural and neural levels measured using functional magnetic resonance imaging during a psychological task . This task was modified from the Sally-Anne Task , a well-known first-order false belief task . The task was optimized for investigation of the abilities to infer another person 's social emotions and beliefs distinctively so as to test the hypothesis that oxytocin improves deficit in inferring others ' social emotions rather than beliefs , under conditions without direct emotional cues . In the case-control study , 17 males with autism spectrum disorder showed significant behavioural deficits in inferring others ' social emotions ( P = 0.018 ) but not in inferring others ' beliefs ( P = 0.064 ) compared with 17 typically developing demographically-matched male participants . They also showed significantly less activity in the right anterior insula and posterior superior temporal sulcus during inferring others ' social emotions , and in the dorsomedial prefrontal cortex during inferring others ' beliefs compared with the typically developing participants ( P < 0.001 and cluster size > 10 voxels ) . Then , to investigate potential effects of oxytocin on these behavioural and neural deficits , we conducted a double-blind placebo-controlled crossover within-subject trial for single-dose intranasal administration of 24 IU oxytocin in an independent group of 20 males with autism spectrum disorder . Behaviourally , oxytocin significantly increased the correct rate in inferring others ' social emotions ( P = 0.043 , one-tail ) . At the neural level , the peptide significantly enhanced the originally-diminished brain activity in the right anterior insula during inferring others ' social emotions ( P = 0.004 ) , but not in the dorsomedial prefrontal cortex during inferring others ' beliefs ( P = 0.858 ) . The present findings suggest that oxytocin enhances the ability to understand others ' social emotions that have also required second-order false belief rather than first-order false beliefs under conditions without direct emotional cues in autism spectrum disorder at both the behaviour and neural levels .
67462
Intervention_Pharmacological
Oxytocin
67463
Intervention_Pharmacological
oxytocin 's
67464
Intervention_Pharmacological
oxytocin
67465
Intervention_Pharmacological
oxytocin
67466
Intervention_Pharmacological
oxytocin
67467
Intervention_Pharmacological
oxytocin
67468
Intervention_Control
placebo-controlled
67469
Intervention_Pharmacological
oxytocin
67470
Intervention_Pharmacological
oxytocin
67471
Intervention_Pharmacological
oxytocin
67472
Outcome_Mental
behavioural and neural deficits
67473
Outcome_Mental
emotion recognition
67474
Outcome_Mental
behavioural deficits in inferring others ' social emotions
67475
Outcome_Mental
inferring others ' beliefs
67476
Outcome_Physical
right anterior insula
67477
Outcome_Mental
correct rate in inferring others ' social emotions
67478
Outcome_Mental
originally-diminished brain activity in the right anterior insula
67479
Outcome_Mental
ability to understand others ' social emotions
67480
Participant_Condition
autism
67481
Participant_Condition
autism spectrum disorder
67482
Participant_Condition
autism spectrum disorder
67483
Participant_Sample-size
17
67484
Participant_Sex
males
67485
Participant_Condition
autism spectrum disorder
67486
Participant_Sample-size
17
67487
Participant_Condition
demographically-matched
67488
Participant_Sex
male
67489
Participant_Sample-size
20
67490
Participant_Condition
autism spectrum disorder